LY3372993

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3372993, covering 2025-03-28 to 2025-03-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3372993 in Participants With Alzheimer's Disease (AD) and Healthy Participants [Phase 1]